NCT07354074 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07354074
Title	Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Novartis Pharmaceuticals
Indications	chronic myeloid leukemia
Therapies	Asciminib
Age Groups:	child \| adult
Covered Countries	AUS

Facility	Status	City	State	Zip	Country	Details
Novartis Investigative Site	RECRUITING	Brisbane	Queensland	4101	Australia	Details
Novartis Investigative Site	RECRUITING	Seoul		03080	South Korea	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07354074Clinical Trial Detail